C4 Therapeutics, Inc. - FORM S-1 - EX-23.1 - September 10, 2020

Attached files

file	filename
EX-21.1 - EX-21.1 - C4 Therapeutics, Inc.	d772024dex211.htm
EX-10.14 - EX-10.14 - C4 Therapeutics, Inc.	d772024dex1014.htm
EX-10.13 - EX-10.13 - C4 Therapeutics, Inc.	d772024dex1013.htm
EX-10.12 - EX-10.12 - C4 Therapeutics, Inc.	d772024dex1012.htm
EX-10.11 - EX-10.11 - C4 Therapeutics, Inc.	d772024dex1011.htm
EX-10.10 - EX-10.10 - C4 Therapeutics, Inc.	d772024dex1010.htm
EX-10.9 - EX-10.9 - C4 Therapeutics, Inc.	d772024dex109.htm
EX-10.8 - EX-10.8 - C4 Therapeutics, Inc.	d772024dex108.htm
EX-10.7 - EX-10.7 - C4 Therapeutics, Inc.	d772024dex107.htm
EX-10.6 - EX-10.6 - C4 Therapeutics, Inc.	d772024dex106.htm
EX-10.5 - EX-10.5 - C4 Therapeutics, Inc.	d772024dex105.htm
EX-10.4 - EX-10.4 - C4 Therapeutics, Inc.	d772024dex104.htm
EX-10.1 - EX-10.1 - C4 Therapeutics, Inc.	d772024dex101.htm
EX-4.2 - EX-4.2 - C4 Therapeutics, Inc.	d772024dex42.htm
EX-4.1 - EX-4.1 - C4 Therapeutics, Inc.	d772024dex41.htm
EX-3.5 - EX-3.5 - C4 Therapeutics, Inc.	d772024dex35.htm
EX-3.4 - EX-3.4 - C4 Therapeutics, Inc.	d772024dex34.htm
EX-3.3 - EX-3.3 - C4 Therapeutics, Inc.	d772024dex33.htm
EX-3.1 - EX-3.1 - C4 Therapeutics, Inc.	d772024dex31.htm
S-1 - S-1 - C4 Therapeutics, Inc.	d772024ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

C4 Therapeutics, Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Boston, Massachusetts

September 10, 2020